MIR145 |
|
microRNA 145
|
|
|
0.431 |
0.846 |
CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
MIRLET7B |
|
microRNA let-7b
|
|
|
0.493 |
0.769 |
LOC102723407 |
|
immunoglobulin heavy variable 4-38-2-like
|
|
|
0.514 |
0.769 |
MIR320A |
|
microRNA 320a
|
|
|
0.526 |
0.808 |
IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
LOC102724971 |
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
|
0.527 |
0.769 |
IL12A-AS1 |
|
IL12A antisense RNA 1
|
|
|
0.633 |
0.654 |
HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
CD177 |
Q8N6Q3
|
CD177 molecule
|
|
|
0.595 |
0.654 |
KIR2DS2 |
P43631
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2
|
|
|
0.599 |
0.615 |
IGHA1 |
P01876
|
immunoglobulin heavy constant alpha 1
|
|
|
0.617 |
0.692 |
WG |
|
Wegener granulomatosis
|
|
|
0.595 |
0.808 |
SERPINA13P |
Q6UXR4
|
serpin family A member 13, pseudogene
|
|
|
0.619 |
0.692 |
LPAL2 |
Q16609
|
lipoprotein(a) like 2, pseudogene
|
Enzyme
|
|
0.626 |
0.731 |
IGHV3-52 |
|
immunoglobulin heavy variable 3-52 (pseudogene)
|
|
|
0.674 |
0.423 |
ATD |
|
asphixiating thoracic dystrophy (chondroectodermal dysplasia-like syndrome)
|
|
|
0.656 |
0.731 |
PLB1 |
Q6P1J6
|
phospholipase B1
|
|
1.7E-72 |
0.488 |
0.846 |
ABCC11 |
Q96J66
|
ATP binding cassette subfamily C member 11
|
Transporter
|
4.0E-46 |
0.565 |
0.769 |
IFIH1 |
Q9BYX4
|
interferon induced with helicase C domain 1
|
|
7.0E-44 |
0.471 |
0.808 |
SCN10A |
Q9Y5Y9
|
sodium voltage-gated channel alpha subunit 10
|
Ion channel
|
9.9E-38 |
0.566 |
0.692 |
ACE |
P12821
|
angiotensin I converting enzyme
|
Enzyme
|
1.0E-37 |
0.328 |
0.923 |
ERAP1 |
Q9NZ08
|
endoplasmic reticulum aminopeptidase 1
|
Enzyme
|
2.1E-26 |
0.556 |
0.692 |
SCN11A |
Q9UI33
|
sodium voltage-gated channel alpha subunit 11
|
Ion channel
|
6.9E-26 |
0.666 |
0.462 |
VWF |
P04275
|
von Willebrand factor
|
Enzyme modulator
|
3.2E-25 |
0.408 |
0.885 |